The Management of T1 Rectal Cancer in the North East of England

ABSTRACT NUMBER: (NESS _ 07)

 

AUTHORS
The Northern Surgical Trainees Research Association

AFFILIATIONS
The Northern Surgical Trainees Research Association

CORRESPONDING AUTHOR CONTACT EMAIL
moc.liamg@nabahsoldaf

MAIN ABSTRACT TEXT

Introduction
Traditional treatment of rectal cancer is major surgical resection. The management of early stages has evolved with increasing emphasis on organ preservation, with a number of endoscopic and local excision options. We explored the management and outcomes of T1 rectal cancer in the North East of England.

Methods
A retrospective, multi-centre, observational cohort-study of all patients with a pT1 rectal cancer across the North East between 1/1/2010 and 31/12/2017 was conducted. Our primary outcome was local recurrence.

Results
402 cases of T1 rectal cancer across 13 sites were identified. Median age was 68.4, and 35% were female. Characteristics of the index procedure are shown in the table below:

 

Index Procedure Number Performed (%) R0 Resection Rate Overall Complication Rate Second Procedure Performed Local Recurrence Metastases Overall

10-year Survival

Major Resection 178 (43.8%) 100% 33.7% 40 2.3% 5.1% 86.9%
Endoscopic 140 (34.5%) 68.2% 6.4% 2 1.4% 1.4% 87.7%
TEMS/TAMIS 69 (17%) 87.3% 21.7% 11 8.7% 8.7% 78.3%
Transanal 6 (1.5%) * 16.7% 3 16.7% 0% 83.3%
Total/Overall 402 88.4% 21.6% 57 (14.1%) 3.2% 4.2% 85.6%
p-Value p<0.001 p<0.001 p=0.511 p=0.769 p=0.163

* missing data

 

Over the study duration was an increase in the TEMS/TAMIS procedure and a decrease in the endoscopic procedures. 22 of the 57 patients who had a second procedure had no residual disease.

Conclusion
Over time there was a trend to perform more local excision procedures. There were no statistically significant differences in local recurrence, metastases or overall survival in relation to the procedure performed.

Share This

Copy Link to Clipboard

Copy